Specialty Medical Society Education & Networking

By prioritizing higher-efficacy influenza vaccines for adults aged 65+ while allowing fallback to any age-appropriate option, we improve overall vaccine effectiveness and coverage in high-risk populations, because older adults have weaker immune responses and are more vulnerable to severe outcomes. This strategy focuses on tailoring vaccine recommendations to age-related physiological differences, specifically enhancing protection for older adults through preferential use of adjuvanted or higher-dose formulations. It balances optimization of efficacy with practical access, ensuring that vaccination is not delayed if preferred vaccines are unavailable. Unlike one-size-fits-all approaches, this method acknowledges immunological aging and prioritizes both clinical effectiveness and care continuity.

By collecting and disseminating practice-relevant data, improve financial sustainability and operational decision-making for healthcare providers, because actionable insights empower informed choices and systemic advocacy. This strategy leverages systematic data collection—such as compensation surveys and coding guidance—to generate evidence that informs members’ business and policy decisions. Unlike broader advocacy or education strategies, it focuses specifically on generating and sharing empirical, practice-level intelligence to directly influence provider behavior and payment accuracy in primary care.